Related Experiment Video
Updated: Jun 8, 2026

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
Total Chemical Synthesis and Folding of All-l and All-d Variants of Oncogenic KRas(G12V)
Adam M Levinson1, John H McGee2, Andrew G Roberts
1Tri-Institutional PhD Program in Chemical Biology, Weill Cornell Medical College , New York, New York 10065, United States.
Abstract:
The Ras proteins are essential GTPases involved in the regulation of cell proliferation and survival. Mutated oncogenic forms of Ras alter effector binding and innate GTPase activity, leading to deregulation of downstream signal transduction. Mutated forms of Ras are involved in approximately 30% of human cancers. Despite decades of effort to develop direct Ras inhibitors, Ras has long been considered "undruggable" due to its high affinity for GTP and its lack of hydrophobic binding pockets. Herein, we report a total chemical synthesis of all-l- and all-d-amino acid biotinylated variants of oncogenic mutant KRas(G12V). The protein is synthesized using Fmoc-based solid-phase peptide synthesis and assembled using combined native chemical ligation and isonitrile-mediated activation strategies. We demonstrate that both KRas(G12V) enantiomers can successfully fold and bind nucleotide substrates and binding partners with observable enantiodiscrimination. By demonstrating the functional competency of a mirror-image form of KRas bound to its corresponding enantiomeric nucleotide triphosphate, this study sets the stage for further biochemical studies with this material. In particular, this protein will enable mirror-image yeast surface display experiments to identify all-d peptide ligands for oncogenic KRas, providing a useful tool in the search for new therapeutics against this challenging disease target.
Insights
Researchers synthesized mirror-image forms of cancer-driving Ras proteins (KRas). These enantiomeric proteins can fold and bind molecules, enabling new therapeutic strategies against difficult cancer targets.
Area of Science:
- Biochemistry
- Chemical Biology
- Oncology
Background:
- Ras proteins are crucial GTPases regulating cell growth and survival.
- Mutated Ras proteins are implicated in ~30% of human cancers, driving uncontrolled proliferation.
- Ras has been historically challenging to target therapeutically due to its biochemical properties.
Purpose of the Study:
- To achieve total chemical synthesis of all-l- and all-d-amino acid variants of oncogenic KRas(G12V).
- To investigate the biochemical properties and functional competency of these enantiomeric Ras proteins.
- To establish a foundation for developing novel therapeutic strategies against oncogenic Ras.
Main Methods:
- Fmoc-based solid-phase peptide synthesis was employed for protein construction.
- Native chemical ligation and isonitrile-mediated activation were used for assembly.
- Enantiomeric KRas(G12V) variants were synthesized and biochemically characterized.
Main Results:
- Successfully synthesized all-l- and all-d-amino acid biotinylated KRas(G12V) variants.
- Demonstrated that both enantiomers of KRas(G12V) can fold and bind nucleotide substrates.
- Observed enantiodiscrimination in nucleotide substrate and binding partner interactions.
Conclusions:
- The synthesis and functional validation of enantiomeric KRas provide a novel biochemical tool.
- This work enables mirror-image yeast surface display for identifying all-d peptide ligands.
- These findings offer a promising new avenue for developing therapeutics against oncogenic KRas.
Related Concept Videos
Cancer
Abnormal Proliferation
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Ras Gene
Ras is a superfamily...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
The Ras Gene
Ras is a superfamily...

